Strokestop II study published in Europace
Zenicor-ECG successfully used in another mass screening study for atrial fibrillation including 28 000 individuals. The goal of the study is to reduce stroke incidences caused by atrial fibrillation. The results from the STROKESTOP II study are now published in Europace.
Stepwise mass screening for atrial fibrillation using N-terminal Pro B-type natriuretic peptide:
The STROKESTOP II study
